FDA Issues Draft Guidance Recommending

On April 13, the Food and Drug Administration (FDA) published a new draft guidance that, for the first time, recommends that sponsors of clinical trials for submission to ...

Related Keywords

,Drug Administration Safety Innovation Act ,Oncology Center ,Human Services ,National Institutes Of Health ,Drug Administration ,Office Of Minority Health ,Department Of Health ,Equitable Research Studies For Everyone Trials Act ,Key Takeaways ,Investigative New Drug ,Biologics License Application ,New Drug Application ,Investigational Device Exemption ,Ethnicity Diversity Plan ,Clinical Trial ,Enrollment Practices ,Ethnicity Specific Data ,Medical Device Clinical Studies ,Ethnicity Data ,Cancer Moonshot ,Improve Clinical Trial ,Equitable Participation ,Clinical Trial Diversity Act ,National Institutes ,Diversifying Investigations ,Equitable Research Studies ,Everyone Trials Act ,Mondaq ,Fda Issues Draft Guidance Recommending Quot Race And Ethnicity Diversity Plans For Clinical Trial Sponsors ,Food ,Drugs ,Healthcare ,Life Sciences ,Food And Drugs Law ,Iotechnology Amp Nanotechnology ,